Literature DB >> 15692818

17beta-Estradiol inhibits calcium-dependent, but not calcium-independent, contraction in isolated rat aorta.

Hae-Ahm Lee1, Yujin Seong, Won-Jung Lee, Inkyeom Kim.   

Abstract

It is now well known that 17beta-estradiol has an endothelium-independent, non-genomic vasorelaxant effect. We hypothesized that 17beta-estradiol has its non-genomic effect on calcium-independent contraction in de-endothelialized rat aortic rings. Rat aortic ring preparations were mounted in organ baths and exposed to contractile agents. 17beta-Estradiol (8, 20 or 50 microM), but not 17alpha-estradiol, concentration-dependently decreased the tension induced by 1.0 microM phenylephrine (PE) in the presence, but not in the absence, of calcium in the solution. Pretreatment with 17beta-estradiol concentration-dependently inhibited vascular contractions induced by cumulative addition of PE or calcium and almost completely abolished those induced by cumulative addition of Bay K8644, a calcium channel opener. Furthermore, 17beta-estradiol also concentration-dependently decreased the tension induced by 0.3 microM phorbol 12,13-dibutyrate (PDBu), a protein kinase C activator, in the presence of calcium in the solution, but not in the absence of calcium in the solution. Pretreatment with 17beta-estradiol had little effect on vascular contractions induced by PDBu or PE or on PE-induced mitogen-activated protein kinase (MAPK) activation in calcium-free Krebs solution. These results suggest that 17beta-estradiol inhibits calcium-dependent, but not calcium-independent, vascular contraction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15692818     DOI: 10.1007/s00210-004-1017-3

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  24 in total

Review 1.  Cell localization, physiology, and nongenomic actions of estrogen receptors.

Authors:  E R Levin
Journal:  J Appl Physiol (1985)       Date:  2001-10

Review 2.  Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells.

Authors:  Y Fukata; M Amano; K Kaibuchi
Journal:  Trends Pharmacol Sci       Date:  2001-01       Impact factor: 14.819

Review 3.  PKC-dependent signalling mechanisms in differentiated smooth muscle.

Authors:  K G Morgan; B D Leinweber
Journal:  Acta Physiol Scand       Date:  1998-12

Review 4.  Signal transduction and regulation in smooth muscle.

Authors:  A P Somlyo; A V Somlyo
Journal:  Nature       Date:  1994-11-17       Impact factor: 49.962

5.  Effect of heat shock on the vascular contractility in isolated rat aorta.

Authors:  Y Kim; J Kim; M Kim; W Baek; I Kim
Journal:  J Pharmacol Toxicol Methods       Date:  1999-11       Impact factor: 1.950

6.  Non-genomic mechanism of 17 beta-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle.

Authors:  T Kitazawa; E Hamada; K Kitazawa; A K Gaznabi
Journal:  J Physiol       Date:  1997-03-01       Impact factor: 5.182

7.  Vascular actions of 17beta-oestradiol in rat aorta and mesenteric artery.

Authors:  M Browne; C Connolly; J R Docherty
Journal:  J Auton Pharmacol       Date:  1999-10

8.  PKC-mediated redistribution of mitogen-activated protein kinase during smooth muscle cell activation.

Authors:  R A Khalil; K G Morgan
Journal:  Am J Physiol       Date:  1993-08

9.  Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding.

Authors:  T C Pappas; B Gametchu; C S Watson
Journal:  FASEB J       Date:  1995-03       Impact factor: 5.191

10.  Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro.

Authors:  A Mügge; M Riedel; M Barton; M Kuhn; P R Lichtlen
Journal:  Cardiovasc Res       Date:  1993-11       Impact factor: 10.787

View more
  3 in total

1.  17beta-estradiol attenuates vascular contraction through inhibition of RhoA/Rho kinase pathway.

Authors:  Enyue Yang; Su Bun Jeon; Inji Baek; Zheng-Ai Chen; Zheng Jin; In Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-19       Impact factor: 3.000

2.  Flavone Attenuates Vascular Contractions by Inhibiting RhoA/Rho Kinase Pathway.

Authors:  Inji Baek; Su Bun Jeon; Min-Ji Song; Enyue Yang; Uy Dong Sohn; In Kyeom Kim
Journal:  Korean J Physiol Pharmacol       Date:  2009-06-30       Impact factor: 2.016

Review 3.  Estrogen and its role in gastrointestinal health and disease.

Authors:  Aisling M Hogan; Danielle Collins; Alan W Baird; Des C Winter
Journal:  Int J Colorectal Dis       Date:  2009-08-05       Impact factor: 2.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.